Vijayalakshmi Ravindranath
#27,423
Most Influential Person Now
Indian neuroscientist
Vijayalakshmi Ravindranath's AcademicInfluence.com Rankings
Vijayalakshmi Ravindranathbiology Degrees
Biology
#2629
World Rank
#4145
Historical Rank
Neuroscience
#494
World Rank
#513
Historical Rank
Download Badge
Biology
Why Is Vijayalakshmi Ravindranath Influential?
(Suggest an Edit or Addition)According to Wikipedia, Vijayalakshmi Ravindranath is an Indian neuroscientist. She is currently a professor at the Centre for Neuroscience, Indian Institute of Science in Bangalore. She was the founder director of the National Brain Research Centre, Gurgaon and founder chair of the Centre for Neuroscience at Indian Institute of Science. Her main area of interest is the study of brain related disorders including neurodegenerative diseases such as Alzheimer's and Parkinson's. She serves as the founding director of the Centre for Brain Research in Bangalore.
Vijayalakshmi Ravindranath's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Grand challenges in global mental health (2011) (1723)
- Absorption and tissue distribution of curcumin in rats. (1980) (418)
- Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver (2012) (295)
- Metabolism of curcumin--studies with [3H]curcumin. (1981) (253)
- Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice (1997) (235)
- World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia (2019) (183)
- α-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats (1996) (173)
- Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death‐associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by α‐lipoic acid (2007) (138)
- Glutathione depletion and formation of glutathione-protein mixed disulfide following exposure of brain mitochondria to oxidative stress. (1990) (136)
- In vitro studies on the intestinal absorption of curcumin in rats. (1981) (136)
- Selective Activation of p38 Mitogen-Activated Protein Kinase in Dopaminergic Neurons of Substantia Nigra Leads to Nuclear Translocation of p53 in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Mice (2008) (123)
- Cytochrome P4502E (CYP2E) in brain: constitutive expression, induction by ethanol and localization by fluorescence in situ hybridization. (2000) (121)
- Glutathione and protein thiol homeostasis in brain during reperfusion after cerebral ischemia. (1995) (121)
- Reactive metabolites from the bioactivation of toxic methylfurans. (1984) (117)
- Inhibition of cystathionine-γ-lyase leads to loss of glutathione and aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS (2007) (100)
- Low glutathione levels in brain regions of aged rats (1989) (99)
- Induction of brain cytochrome P-450IIE1 by chronic ethanol treatmen (1993) (93)
- Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics (2001) (91)
- Synapse loss and progress of Alzheimer’s disease -A network model (2019) (91)
- Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation (1999) (88)
- Glutaredoxin is essential for maintenance of brain mitochondrial complex I: studies with MPTP (2003) (85)
- A Frameshift Mutation and Alternate Splicing in Human Brain Generate a Functional Form of the Pseudogene Cytochrome P4502D7 That Demethylates Codeine to Morphine* (2004) (83)
- Oxidative stress and thiol modification induced by chronic administration of haloperidol. (1993) (82)
- Estrogen and neuroprotection: higher constitutive expression of glutaredoxin in female mice offers protection against MPTP‐mediated neurodegeneration (2004) (79)
- Knockdown of Cytosolic Glutaredoxin 1 Leads to Loss of Mitochondrial Membrane Potential: Implication in Neurodegenerative Diseases (2008) (78)
- Xenobiotic metabolism in human brain — presence of cytochrome P-450 and associated mono-oxygenases (1989) (77)
- Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF‐κB in MPTP‐treated mice: implication in Parkinson’s disease (2009) (75)
- Aβ mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease (2017) (73)
- Rat brain cytochromes P-450: catalytic, immunochemical properties and inducibility of multiple forms (1990) (72)
- alpha-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats. (1996) (66)
- Constitutive expression and localization of the major drug metabolizing enzyme, cytochrome P4502D in human brain. (2002) (65)
- Drug Metabolism in Human Brain: High Levels of Cytochrome P4503A43 in Brain and Metabolism of Anti-Anxiety Drug Alprazolam to Its Active Metabolite (2008) (65)
- Brain mitochondrial cytochromes P450: xenobiotic metabolism, presence of multiple forms and their selective inducibility. (1995) (60)
- Free radical scavenging systems in developing rat brain (1991) (53)
- Multiple forms of cytochrome P450 and associated monooxygenase activities in human brain mitochondria. (2000) (52)
- Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease (2017) (52)
- Metabolic activation of 2-methylfuran by rat microsomal systems. (1985) (50)
- Constitutive expression and localization of cytochrome P‐450 1A1 in rat and human brain: presence of a splice variant form in human brain 1 (2005) (49)
- Oxidative stress induced by administration of the neuroleptic drug haloperidol is attenuated by higher doses of haloperidol (1992) (49)
- NADPH cytochrome P-450 reductase in rat, mouse and human brain. (1990) (48)
- Xenobiotic metabolism in brain. (1995) (48)
- Constitutive expression and functional characterization of mitochondrial glutaredoxin (Grx2) in mouse and human brain (2007) (48)
- Neurolathyrism: mitochondrial dysfunction in excitotoxicity mediated by l-β-oxalyl aminoalanine (2002) (46)
- Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite (2002) (45)
- Preparation of brain microsomes with cytochrome P450 activity using calcium aggregation method. (1990) (45)
- Flavin-containing monooxygenase mediated metabolism of psychoactive drugs by human brain microsomes (1995) (44)
- Xenobiotic metabolism in brain. (1995) (44)
- Animal models and molecular markers for cerebral ischemia-reperfusion injury in brain. (1994) (44)
- DJ-1 loss by glutaredoxin but not glutathione depletion triggers Daxx translocation and cell death. (2010) (43)
- Redox modification of Akt mediated by the dopaminergic neurotoxin MPTP, in mouse midbrain, leads to down‐regulation of pAkt (2012) (42)
- Fenofibrate Reduces Mortality and Precludes Neurological Deficits in Survivors in Murine Model of Japanese Encephalitis Viral Infection (2012) (41)
- Metabolism of xenobiotics in the central nervous system: implications and challenges. (1998) (39)
- 2-Methylfuran toxicity in rats--role of metabolic activation in vivo. (1986) (39)
- Depletion of gluththione and enhanced lipid peroxidation in the CSF of acute psychotics following haloperidol administration (1994) (39)
- Thioltransferase (Glutaredoxin) Mediates Recovery of Motor Neurons from Excitotoxic Mitochondrial Injury (2002) (38)
- Cytochrome P450-mediated metabolism in brain: functional roles and their implications (2013) (37)
- Microsomal cytochrome P450 in human brain regions. (1992) (36)
- Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction in female mice CNS: Implications in excitotoxicity (2007) (35)
- Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization. (1993) (35)
- Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. (2011) (34)
- MPTP activates ASK1-p38 MAPK signaling pathway through TNF-dependent Trx1 oxidation in parkinsonism mouse model. (2015) (34)
- Rat Brain Thioltransferase : Regional Distribution, Immunological Characterization, and Localization by Fluorescent In Situ Hybridization (1999) (34)
- Toxicological consequences of differential regulation of cytochrome p450 isoforms in rat brain regions by phenobarbital. (2002) (32)
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced complex I inhibition is reversed by disulfide reductant, dithiothreitol in mouse brain (2000) (32)
- Critical cysteines in Akt1 regulate its activity and proteasomal degradation: implications for neurodegenerative diseases. (2014) (32)
- Production of deoxynivalenol by Fusarium isolates from samples of wheat associated with a human mycotoxicosis outbreak and from sorghum cultivars (1989) (31)
- Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activities. (1993) (31)
- High activity of cytochrome P-450-linked aminopyrine N-demethylase in mouse brain microsomes, and associated sex-related difference. (1989) (31)
- Regulation of DJ-1 by Glutaredoxin 1 in Vivo: Implications for Parkinson's Disease. (2016) (30)
- Regional research priorities in brain and nervous system disorders (2015) (29)
- l-BOAA induces selective inhibition of brain mitochondrial enzyme, NADH-dehydrogenase (1993) (29)
- Effect of thiol modification on brain mitochondrial complex I activity (1999) (28)
- Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: the convolution continues (2006) (28)
- Expression of multiple forms of cytochrome P450 and associated mono-oxygenase activities in rat brain regions. (1998) (27)
- Cerebral Metabolism of Imipramine and a Purified Flavin-Containing Monooxygenase from Human Brain (1996) (27)
- Characterization of a phenobarbital-inducible cytochrome P-450, NADPH-cytochrome P-450 reductase and reconstituted cytochrome P-450 mono-oxygenase system from rat brain. Evidence for constitutive presence in rat and human brain. (1992) (27)
- Protection and potentiation of MPTP-induced toxicity by cytochrome P-450 inhibitors and inducer: in vitro studies with brain slices (1991) (23)
- Cytochrome P450 and assocaited monooxygenase activities in the rat and human spinal cord: Induction, immunological characterization and immunocytochemical localization (1995) (23)
- Rat brain cytochrome P450. Reassessment of monooxygenase activities and cytochrome P450 levels. (1995) (22)
- Detection and localization of protein-acetaldehyde adducts in rat brain after chronic ethanol treatment. (2002) (22)
- Selective modulation of glutathione in mouse brain regions and its effect on acrylamide-induced neurotoxicity. (1992) (22)
- Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran. (1991) (21)
- Billionfold difference in the toxic potencies of two excitatory plant amino acids, L-BOAA and L-BMAA: biochemical and morphological studies using mouse brain slices (1993) (21)
- γ-Glutamyl cysteine synthetase is up-regulated during recovery of brain mitochondrial complex I following neurotoxic insult in mice (2003) (20)
- Redox Activated MAP Kinase Death Signaling Cascade Initiated by ASK1 is not Activated in Female Mice Following MPTP: Novel Mechanism of Neuroprotection (2009) (20)
- Impact of age, gender, and education on the performance of Addenbrooke’s Cognitive Examination (ACE‐ III) in urban and rural Indians (2020) (19)
- An alternatively spliced cytochrome P4501A1 in human brain fails to bioactivate polycyclic aromatic hydrocarbons to DNA‐reactive metabolites (2007) (19)
- Down-regulation of glutaredoxin by estrogen receptor antagonist renders female mice susceptible to excitatory amino acid mediated complex I inhibition in CNS (2006) (18)
- Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer’s disease mice and correlates with memory deficits in human subjects (2018) (18)
- Presence of flavin-containing monooxygenase in rat brain. (1991) (17)
- Withania somnifera Extract Protects Model Neurons from In Vitro Traumatic Injury (2017) (16)
- Glutathione homeostasis in brain during reperfusion following bilateral carotid artery occlusion in the rat (1992) (16)
- Protection and Potentiation of 1‐Methyl‐4‐Phenylpyridinium‐Induced Toxicity by Cytochrome P450 Inhibitors and Inducer May Be Due to the Altered Uptake of the Toxin (1995) (14)
- A simple and inexpensive slicer for preparation of brain slices (1991) (14)
- Changing demography and the challenge of dementia in India (2021) (14)
- Human brain thioltransferase: constitutive expression and localization by fluorescence in situ hybridization. (2000) (14)
- Unique cytochromes P450 in human brain: implication in disease pathogenesis. (2006) (14)
- Hepatotoxicity of precocene I in rats. Role of metabolic activation in vivo. (1987) (12)
- Glutaredoxin1 diminishes Aβ mediated oxidation of F-actin and reverses cognitive deficits in an Alzheimer's disease mouse model. (2019) (12)
- Honokiol reverses depressive-like behavior and decrease in brain BDNF levels induced by chronic corticosterone injections in mice (2013) (12)
- CaV1.3 L-Type Calcium Channels Increase the Vulnerability of Substantia Nigra Dopaminergic Neurons in MPTP Mouse Model of Parkinson’s Disease (2020) (12)
- Administration of testosterone alleviates the constitutive sex difference in rat brain cytochrome P-450 (1991) (11)
- Further characterization of rat brain flavin-containing monooxygenase. Metabolism of imipramine to its N-oxide. (1996) (11)
- Presence of splice variant forms of cytochrome P4502D1 in rat brain but not in liver. (2005) (10)
- The use of rat brain slices as an in vitro model for mechanistic evaluation of neurotoxicity-studies with acrylamide. (1991) (10)
- Toxicity of N-acetylaspartylglutamate and its protection by NMDA and non-NMDA receptor antagonists (1991) (9)
- Catalytic activity and immunohistochemical localization of flavin-containing monooxygenase in rat kidney. (1993) (8)
- Reactive Oxygen Species-Mediated Loss of Synaptic Akt 1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer ’ s Disease (2017) (8)
- Syntheses of 2‐([14C]methyl)furan and 4‐oxo[5‐14C]‐2‐pentenal (1984) (6)
- Glutaredoxin1 Diminishes Amyloid Beta-Mediated Oxidation of F-Actin and Reverses Cognitive Deficits in an Alzheimer's Disease Mouse Model (2019) (6)
- C onstitutive expression and localization of the major drug metabolizing enzyme , cytochrome P 4502 D in human brain (2002) (6)
- Thiol Oxidation by Diamide Leads to Dopaminergic Degeneration and Parkinsonism Phenotype in Mice: A Model for Parkinson's Disease. (2016) (5)
- Burden of Vitamin D, Vitamin B12 and Folic Acid Deficiencies in an Aging, Rural Indian Community (2021) (5)
- The influence of MTR A2756G polymorphism on plasma homocysteine in young south Indians. (2008) (5)
- Quisqualic acid-induced neurotoxicity is protected by NMDA and non-NMDA receptor antagonists (1992) (4)
- Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice (2020) (4)
- Rural-urban and gender differences in metabolic syndrome in the aging population from southern India: Two parallel, prospective cohort studies (2022) (4)
- Withania somnifera Extract Protects Model Neurons from In Vitro Traumatic Injury (2016) (3)
- Srinivaspura Aging, Neuro Senescence and COGnition (SANSCOG) study and Tata Longitudinal Study on Aging (TLSA): Study protocols (2020) (3)
- Characterization and localization of cytochrome P450 mediated metabolism of MPTP to nor-MPTP in mouse brain: Relevance to Parkinson’s disease (2001) (3)
- Endothelin-1 mediated vasoconstriction leads to memory impairment and synaptic dysfunction (2021) (3)
- RESPONSE TO COMMENT ON “A FRAMESHIFT MUTATION AND ALTERNATE SPLICING IN HUMAN BRAIN GENERATE A FUNCTIONAL FORM OF THE PSEUDOGENE CYTOCHROME P4502D7 THAT DEMETHYLATES CODEINE TO MORPHINE” (2005) (3)
- Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson’s disease (2020) (2)
- Complex I Assay in Mitochondrial Preparations from CNS (2008) (2)
- Srinivaspura Aging, Neuro Senescence and COGnition (SANSCOG) study: Study protocol. (2022) (2)
- Normative data for three physical frailty parameters in an aging, rural Indian population (2022) (2)
- Occurrence, distribution and potential actions of CYP2D6 in the brain (2014) (1)
- Pharmacological and toxicological significance of brain cytochromes P450 (2001) (1)
- HEPATIC LIPOPROTEIN RECEPTOR RELATED PROTEIN MODULATORS AS POTENTIAL THERAPEUTICS FOR ALZHEIMER'S DISEASE (2019) (1)
- Comparison of obesity, diabetes, hypertension and depression in two parallel, aging study cohorts from rural and urban India: SANSCOG study and TLSA (2020) (1)
- Spectrophotometric Assay of Oxidized Glutathione Using Iodoacetic Acid and Enzymatic Recycling Method (1991) (1)
- MRI investigations of white matter hyperintensity and structural abnormalities of brain in urban and rural cohorts of India (2020) (1)
- Approaches to engage an aging, rural cohort in southern India during the COVID‐19 crisis and the psychological impact of COVID‐19 in this cohort (2022) (1)
- Histological, histochemical and autoradiographic evidence of in vitro neurotoxic effects of the novel antitumor agent, 9-methoxy-N2-methylellipticinium acetate. (1997) (1)
- Alzheimer’s Association International Cohort Study of Chronic Neuropsychiatric Sequeale of SARS‐CoV‐2 (CNS‐SARS‐CoV‐2) (2020) (1)
- Relation between CAIDE scores and cognition: Data from TATA Longitudinal Study of Ageing (2020) (1)
- Drug metabolizing enzyme systems and their relationship to toxic mechanisms (1985) (1)
- Post synaptic density 95 (PSD95)–Actin interaction: A critical regulator of synaptic strength and plasticity in Alzheimer’s disease pathology (2022) (0)
- Single bilateral injection of endothelin‐1 leads to temporary deficits in memory and synaptic dysfunction (2020) (0)
- Role of white matter hyperintensities, hemoglobin and vitamin B‐12 on cognitive decline: Two‐year follow‐up data from the Tata Longitudinal Study of Ageing (TLSA) (2020) (0)
- Differential expression of Mical2 and its activator (Sema3a) in Alzheimer’s disease mouse model (2022) (0)
- TRANSIENT VASOCONSTRICTION LEADS TO MEMORY IMPAIRMENT AND SYNAPTIC DYSFUNCTION SIMILAR TO ALZHEIMER’S DISEASE PATHOLOGY (2019) (0)
- Impairment in recall after contextual fear conditioning and activity dependent protein translation in ovariectomized Alzheimer’s disease mouse model (2020) (0)
- Rural‐urban and gender differences in the prevalence of metabolic syndrome among older Indians (2022) (0)
- Global gene expression analysis using microarray to study differential vulnerability to neurodegeneration (2010) (0)
- Role of APOE ε gene in cognitive performance among cognitively healthy participants of TLSA cohort (2022) (0)
- Presence of Phenobarbital and 3-Methylcholanthrene Inducible Forms of Cytochrome P-450 in Rat Brain (1990) (0)
- Recurrent vascular insult leads to memory impairment and synaptic dysfunction detected as F‐actin loss (2020) (0)
- Depression and anxiety during the two waves of the COVID‐19 pandemic in two large, prospective, aging cohorts in rural and urban India. (2022) (0)
- Gender differences in cognitive performance among health volunteers of SANSCOG cohort (2022) (0)
- Prevalence of neuropsychiatric conditions in two parallel, aging study cohorts from rural and urban India (2021) (0)
- Approaches to overcome recruitment challenges in a rural setting in India: Strategies adopted in Srinivasapur Aging, Neuro Senescence and Cognition (SANSCOG) study (2020) (0)
- EARLY STRUCTURAL AND BEHAVIOURAL DIFFERENCES IN APPSWE/PS1ΔE9 MOUSE MODEL OF ALZHEIMER’S DISEASE (2018) (0)
- SYNAPTIC TRANSCRIPTOMIC PROFILE OF A MOUSE MODEL OF ALZHEIMER’S DISEASE REVEALS DIFFERENTIAL EXPRESSION OF GENES INVOLVED IN PROTEIN TRANSLATION (2019) (0)
- CHAPTER 8:Redox Signalling in Dopaminergic Cell Death and Survival (2017) (0)
- Sex difference in evolution of cognitive decline: studies on mouse model and the Dominantly Inherited Alzheimer Network cohort (2023) (0)
- Thioltransferase up-regulation is a critical event during recovery of CNS from oxidative stress generated by excitatory amino acid (2001) (0)
- RESPONSE TO COMMENTS ON HOSKINS ET AL. [(2005) DRUG METAB DISPOS 33:1564–1565] (2006) (0)
- ROS-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease (2016) (0)
- Sex‐specific differences in cognitive functions and synaptic dysfunction in an Alzheimer’s disease mouse model (2021) (0)
- Sex‐specific differential gene expression changes in young AD transgenic (APPswe/PS1ΔE9) mice through RNA‐seq (2020) (0)
- Approaches to engage an aging cohort in rural India during the COVID‐19 crisis and the psychological impact of COVID‐19 in this cohort (2021) (0)
- Protein Glutathionylation and Glutaredoxin: Role in Neurodegenerative Diseases (2022) (0)
- MOUSE MODEL OF VASCULAR DEMENTIA (2018) (0)
- Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer’s disease mice and correlates with memory deficits in human subjects (2018) (0)
- Supervised machine learning method tailored for five brain MRI events is predictive of cognitive status (2021) (0)
- P3.138 Perturbation of protein thiol homeostasis through downregulation of glutaredoxin, a protein disulflde oxidoreductase, results in loss of DJ-1 through proteolysis (2009) (0)
- RNASEQ DATA ANALYSIS REVEALS SEX-SPECIFIC DIFFERENTIAL GENE EXPRESSION IN ALZHEIMER’S DISEASE (2019) (0)
- P3.124 Redox driven apoptotic signaling underlies 'selectivity vulnerability' in animal model of Parkinson's disease (2009) (0)
- VASCULAR CONSTRICTION BY ENOTHELIN-1 AUGMENTS ALZHEIMER’S DISEASE PATHOLOGY (2019) (0)
- GLUTAREDOXIN1 OVEREXPRESSION AMELIORATES EARLY F-ACTIN LOSS AND COGNITIVE DEFICITS SEEN IN ALZHEIMER’S DISEASE MOUSE MODEL (2018) (0)
- AAIC Satellite Symposium explores Alzheimer's disease research in South Asia (2019) (0)
- Synaptosomal actin interactome analysis in an Alzheimer’s disease mouse model (2021) (0)
- 43-2 Cytochrome P-450 in animal and human brain (1997) (0)
- ALTERATIONS IN TRANSCRIPTOME PROFILE IN YOUNG AD TRANSGENIC (APPSWE/PS1ΔE9) MICE (2018) (0)
- ET-1 mediated vasoconstriction leads to memory impairment and synaptic dysfunction reminiscent of Alzheimer’s disease phenotype (2020) (0)
- Overexpression of novel candidate gene ameliorates dendritic simplification in hippocampal neurons from APP/PS1 mouse model of AD (2020) (0)
- Comparison of fasting blood sugar, HbA1c, vitamin B12, homocysteine and vitamin D in two parallel, aging study cohorts from rural and urban India: SANSCOG study and TLSA (2020) (0)
- Depression and anxiety during the first and second waves of the COVID‐19 pandemic in two large, prospective, aging cohorts in rural and urban India (2022) (0)
- Oxidative Stress Mediated Loss of Synaptosomal F-Actin Occurs Prior to Onset of Pathophysiological Hallmarks of Alzheimer's Disease (2016) (0)
- SYNAPTOSOMAL F-ACTIN LOSS OCCURS EARLY IN ALZHEIMER’S DISEASE MOUSE MODEL AND LEADS TO CONTEXTUAL FEAR CONDITIONING (CFC) BEHAVIORAL DEFICITS (2017) (0)
- Synaptosomal actin interactome analysis in an Alzheimer’s disease mouse model (2020) (0)
- Progression in WMH volume is accompanied by higher gray matter loss: One‐year follow‐up MRI study in TATA Longitudinal Study on Aging Cohort of India (2021) (0)
- Novel Anti-Oxidant V2O5 Nanowires Prevent Spine Loss in Primary Cortical Neurons Derived from a Mouse Model of Alzheimer′s Disease (2016) (0)
- 2.423 Redox modification of protein kinase B: Implications for neurodegeneration in Parkinson's disease (2007) (0)
- Comparison of risk factors for dementia among rural and urban elderly adults-data from two cohort studies in India. (2022) (0)
- F-ACTIN NANO-ARCHITECTURE IS COMPROMISED IN DENDRITIC SPINES OF PRIMARY NEURONS FROM APP/PS1 MICE AND IS RESTORED BY GLUTAREDOXIN-1 (2017) (0)
- P3-169 TOPOLOGICAL DISTRIBUTION OF STRESS HORMONE RECEPTORS GR AND MR IN RAT BRAIN (2019) (0)
- LOSS OF F-ACTIN IN SYNAPTOSOMES CORRELATES WITH COGNITIVE DYSFUNCTION (BRAAK STAGING, B-AMYLOID LOAD AND TANGLE LOAD) IN PATIENTS WITH MCI AND AD (2017) (0)
- Comparison of modifiable risk factors for dementia among rural and urban elderly adults: Data from two cohorts in India (2021) (0)
- Prevalence of neuropsychiatric conditions and cognitive impairment in two parallel, aging study cohorts from rural and urban India. (2022) (0)
- Neuroinformatics: Indian perspective (2002) (0)
- THE APOE EPSILON4 ALLELE IS ASSOCIATED WITH MILD COGNITIVE IMPAIRMENT/ALZHEIMER’S DISEASE STATUS IN SOUTH INDIANS (2017) (0)
- ROLE OF AKT-MTOR SIGNALING IN EARLY HIPPOCAMPAL DYSFUNCTION IN A TRANSGENIC MOUSE MODEL OF ALZHEIMER’S DISEASE (2019) (0)
- THE EPSILON4 ALLELE FREQUENCY OF APOE AND ITS ASSOCIATION WITH MILD COGNITIVE IMPAIRMENT/ALZHEIMER’S DISEASE STATUS IN SOUTH INDIANS (2018) (0)
- SEX-SPECIFIC DIFFERENCES IN THE SEQUELAE OF BEHAVIOURAL AND SYNAPTIC DYSFUNCTION IN AN ALZHEIMER’S DISEASE MOUSE MODEL (2019) (0)
- Production ofDeoxynivalenol byFusariumIsolates fromSamplesof WheatAssociated with a HumanMycotoxicosis Outbreak andfromSorghumCultivars (1989) (0)
- COGNITO (Computerized assessment of adult information processing): Normative scores for a rural Indian population from the SANSCOG study. (2022) (0)
- Blood brain barrier dysfunction caused by repeated Endothelin‐1 injection leads to irreversible memory impairment (2021) (0)
- Thiol Oxidation Mediated Redox Signaling Triggers Specific Dopaminergic Neurodegeneration in Parkinson′s Disease (2016) (0)
- Overexpression of Glutaredoxin Averts F-Actin Loss in Spines of Primary Cortical Neurons Derived from Mouse Model of Alzheimer's Disease (2016) (0)
This paper list is powered by the following services:
Other Resources About Vijayalakshmi Ravindranath
What Schools Are Affiliated With Vijayalakshmi Ravindranath?
Vijayalakshmi Ravindranath is affiliated with the following schools:
